text.skipToContent text.skipToNavigation
You searched for "kinetic chromogenic"
Too many choices? Use the filter option on the left to narrow your product listing.
51-58 of 58 results
  • TheraPEAK<sup class=reg>®</sup> P3 Primary Cell Nucleofector<sup class=reg>®</sup>  Solution Set (22.5 mL + 5 mL)
    Compare
    TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (22.5 mL + 5 mL)
    Catalog #: G4LP3-22500

    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.

    Sales unit: items
    ST
  • TheraPEAK<sup class=reg>®</sup> P3 Primary Cell Nucleofector<sup class=reg>®</sup> Solution Set (126 mL + 28 mL)
    Compare
    TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (126 mL + 28 mL)
    Catalog #: G4LP3-126000

    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.

    Sales unit: items
    ST
  • DonorPlex<sup>TM</sup> Pooled Donor Human Hepatocytes, 10 Donor, Female
    Compare
    DonorPlexTM Pooled Donor Human Hepatocytes, 10 Donor, Female
    Catalog #: HUCS10PF
    Pooled 10-donor female only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
    Sales unit: Ampule
    AMP
  • DonorPlex<sup>TM</sup> Pooled Donor Human Hepatocytes, 20 Donor, Female
    Compare
    DonorPlexTM Pooled Donor Human Hepatocytes, 20 Donor, Female
    Catalog #: HUCS20PF
    Pooled 20-donor, female only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
    Sales unit: Ampule
    AMP
  • DonorPlex™ Pooled Donor Human Hepatocytes, 50 Donor, Mixed Gender
    Compare
    DonorPlex™ Pooled Donor Human Hepatocytes, 50 Donor, Mixed Gender
    Catalog #: HUCS50P
    Pooled 50-donor, mixed-gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
    Sales unit: Ampule
    AMP
  • DonorPlex<sup>TM</sup> Pooled Donor Human Hepatocytes, 10 Donor, Male
    Compare
    DonorPlexTM Pooled Donor Human Hepatocytes, 10 Donor, Male
    Catalog #: HUCS10PM

    Pooled 10-donor, male human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.

    Sales unit: Ampule
    AMP
  • DonorPlex<sup>TM</sup> Pooled Donor Human Hepatocytes, 10 donor, mixed gender
    Compare
    DonorPlexTM Pooled Donor Human Hepatocytes, 10 donor, mixed gender
    Catalog #: HUCS10P

    Pooled 10-donor, mixed-gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.

    Sales unit: Ampule
    AMP
  • DonorPlex<sup>TM</sup> Pooled Donor Human Hepatocytes, 20 Donor, Male
    Compare
    DonorPlexTM Pooled Donor Human Hepatocytes, 20 Donor, Male
    Catalog #: HUCS20PM

    Pooled 20-donor male only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.

    Sales unit: Ampule
    AMP
1-10 of 879 results
  • Undirected Migration Assay of NK Cells
    Video of the undirected migration of NK-92 cell line, recorded with the CytoSMART™ System (frame interval: 1 minute) and analyzed by the Tracking Tool™ PRO cell tracking software (Gradientech). (Video courtesy of Trutz Fischer, Martin Luther University of Halle-Wittenberg)
    Watch Video
  • 4D-Nucleofector® Protocol for NK-92
    Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for NK-92
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • NK-92 Transfection Protocol - Nucleofector™ 1/2 Device Series
    Instructions of use for transfection of NK-92 cells with the Cell Line Nucleofector™ Kit R
  • Natural Killer (NK) Cell Culture, Activation and Cytotoxicity Assay
    Protocol instructions
  • Transfection Protocol for Human NK Cells - Nucleofector™ 1/2 Device Series
    Instructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic Research
    Lonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
  • Lonza DNA markers and ladders – Sizing made easy
    Lonza_LabelsInserts_Lonza_DNA_markers_and_ladders__Sizing_made_easy.pdf
  • Gene Expression Data Differentiated SubQ Adipo
    Lonza_SupplementalCellInfo_Gene_Expression_Data_Differentiated_SubQ_Adipo.xls